Physician profile
David G Conyack
NPI 1558402768
$8,241.43
in general payments reported to CMS, 2019-2025
45 companies · $496 in 2025
The $496 reported for 2025 was more than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,854 · 2020: $1,694 · 2021: $1,813 · 2022: $1,233 · 2023: $676 · 2024: $475 · 2025: $496.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,647.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,647.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $1,914.33 | 2019-2025 | Xtampza |
| Abbott Laboratories | $776.77 | 2019-2024 | Proclaim, Eterna |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $490.68 | 2019-2022 | |
| Biodelivery Sciences International, INC. | $486.35 | 2019-2021 | |
| Arbor Pharmaceuticals, INC. | $417.12 | 2019-2022 | |
| Boston Scientific Corporation | $395.42 | 2020-2021 | |
| Abbvie INC. | $385.69 | 2021-2025 | Ubrelvy, Qulipta, Botox |
| Si-Bone, INC. | $370.25 | 2019-2021 | |
| Sentynl Therapeutics, INC. | $215.32 | 2019-2020 | |
| Scilex Pharmaceuticals INC. | $197.98 | 2019-2022 | |
| Horizon Therapeutics Plc | $166.17 | 2019-2020 | |
| Almatica Pharma LLC | $162.39 | 2021-2022 | |
| Heron Therapeutics, INC. | $146.90 | 2021-2022 | |
| Medtronic USA, INC. | $143.22 | 2019-2020 | |
| Bard Access Systems, INC. | $140.74 | 2019 |
Show all 45 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Conyack listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.